drugset / Trial / NCT02742909

Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease

NCT02742909 ↗

Phase 4 Completed 9 enrolled LI ZHAO
RandomizedCrossoverDouble-blindTreatment

Summary

To evaluate the acute effect of recombinant human brain natriuretic peptide(rhBNP) on pulmonary hypertension of acute exacerbations of chronic pulmonary disease. rhBNP was administered as a continuous infusion for 24 hours , pulmonary artery pressure and other hemodynamic parameters were monitored by Swan- Ganz catheter.

Timeline

Start
2015-12
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator rhBNP Peptide 0.0075 ug/kg Intravenous